Cancer, infectious diseases drive point-of-care sensor adoption, says Lux Research

May 8, 2015
Sensor-based point-of-care medical devices will first make an impact in cancer care and infectious diseases, according to Lux Research.

Sensor-based point-of-care medical devices that can be used outside hospitals will first make an impact in cancer care and infectious diseases as rapid innovation, coupled with regulatory and insurer enthusiasm, drives adoption, according to Lux Research (Boston, MA).

Three major sensing technologies—imaging, optical molecular, and electrochemical—will be ready for strong adoption in oncology by 2030, while the more challenging infectious diseases will see similar adoption, but mainly of electrochemical sensors.

Lux Research analysts evaluated key point-of-care sensing technology families to predict likely adoption curves in key clinical indication spaces. Findings include:

  • Over the next decade, optical coherence tomography (OCT) will emerge as the dominant imaging technology in cancer care as novel imaging modalities start disrupting large legacy systems such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET).
  • Infectious diseases pose a big challenge for medical sensors, mainly on account of the sheer number of pathogens. Most approaches focus on in vitro diagnostics (IVD), with electrochemical sensors seeing the largest adoption due to high stability.
  • Sensors for neurology are less mature than those for infectious diseases and cancer, but potentially represent the largest opportunity in the long run due to demographic and epidemiological trends. Electrodes and imaging will lead the pack for neurological uses.

The report, titled "Sensing (Is) the Future of Health Care: Technology Roadmapping Helps Find the Way," is part of the Lux Research BioElectronics Intelligence service.


Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Flexible, Thixotropic, One Component Dual Cure Epoxy

Dec. 1, 2023
Master Bond UV23FLDC-80TK is a moderate viscosity, cationic type system that offers both UV light and heat curing mechanisms. It cures readily within 20-30 seconds when exposed...

MRF Polishing

Dec. 1, 2023
Welcome to Avantier, your esteemed partner in optical solutions for over five decades. With a legacy of expert knowledge, we invite you to delve into the realm of precision optics...

Fluorescence Microscopy Part 1: Illuminating Samples for High-Resolution Imaging

Dec. 1, 2023
Illuminating Samples Fluorescence microscopy is a powerful imaging technique widely used in various fields, especially in biomedical research, to visualize and study fluorescently...

Photonics Business Moves: December 1, 2023

Dec. 1, 2023
Here are the top four photonics business moves that made headlines during the week ending December 1, 2023.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!